Fall 2015


0
BiosimilarOnslaught_Header

The Biosimilar Onslaught

January 05, 2016 / by Kevin Shi and Nawid Sayed / 0 Comment

Pharmaceutical companies face huge revenue uncertainties after the loss of patent exclusivity; but not all is lost.

pebble-header

Creating an Enterprise-Sized Ripple

December 16, 2015 / by Monique Tuin and Leroi Yu / 0 Comment

The consumer market for smartwatches will become saturated by Apple and Android devices; Pebble needs to respond quickly